Answers are grounded in this paper and cite their sources.
Data have demonstrated adverse health effects of sleep deprivation. We postulate that oxidative stress and systemic inflammation biomarkers will be elevated in relation to short-term and long-term sleep duration reduction. We analyzed data from the baseline examination of a randomized controlled trial involving participants with moderate to severe obstructive sleep apnea (OSA). Baseline polysomnography provided the total sleep time (PSG-TST, primary predictor); self-reported habitual sleep duration (SR-HSD) data was collected. Morning measures of oxidative stress and systemic infammation included: myeloperoxidase (MPO, pmol/L), oxidized low-density lipoprotein (ox-LDL, U/L), F2-isoprostane (ng/mg), paraoxonase 1 (PON1, nmol•min−1•mL−1), and aryl esterase (µmol•min−1•mL−1). Linear models adjusted for age, sex, race, body mass index (BMI), cardiovascular disease (CVD), smoking, statin/anti-infammatory medications, and apnea-hypopnea index were utilized (beta estimates and 95% confdence intervals). One hundred forty-seven participants comprised the final analytic sample; they were overall middle-aged (51.0 ± 11.7 y), obese (BMI = 37.3 ± 8.1 kg/m2), and 17% had CVD. Multivariable models demonstrated a significant inverse association of PSG-TST and MPO (β [95% CI] = −20.28 [−37.48, −3.08], P = 0.021), i.e., 20.3 pmol/L MPO reduction per hour increase PSG-TST. Alternatively, a significant inverse association with ox-LDL and SR-HSD was observed (β [95% CI] = 0.98 [0.96, 0.99], P = 0.027), i.e., 2% ox-LDL reduction per hour increase SR-HSD. Even after consideration of obesity and OSA severity, inverse significant findings were observed such that reduced PSG-TST was associated with elevated MPO levels and SR-HSD with ox-LDL, suggesting differential up-regulation of oxidative stress and pathways of inflammation in acute versus chronic sleep curtailment. NIH clinical trials registry number NCT00607893. Although data have implicated up-regulation of systemic inflammation and oxidative stress in obstructive sleep apnea (OSA), the extent to which polysomnographically-ascertained reduced sleep duration (PSG-TST) versus subjective chronic habitual reduction of self-reported sleep duration (SR-HSD) relates to these pathways remain unclear. We identify differential linear increases of oxidative stress and systemic inflammation measures—recognized established markers of cardiovascular risk—in relation to reduced sleep duration in moderate to severe OSA. Increases in myeloperoxidase levels were observed with reduction PSG-TST versus increases in oxidized LDL with reduction of SR-HSD after consideration of confounders including obesity and cardiovascular risk. Future investigation should focus on further clarification of the role of reduced sleep in OSA in relation to risk of cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
DeMartino et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: